Discontinued operation lifts NPAT 449.7% as pre-lease FCF swings to -$33.7m

Headline NPAT rose 449.7% to $17.2m, but $11.6m of that came from the discontinued-operation line; continuing-operations NPAT was $5.6m versus -$4.9m in HY21. Continuing-operations revenue was $29.8m at a stated ~66% EBITDA margin, so the -74.1% revenue and -52.6% EBITDA comparisons reflect a base-mix change rather than deterioration in the ongoing business.

Operating cash flow swung from +$22.4m to -$14.8m and pre-lease free cash flow moved to -$33.7m from +$1.2m. Gross borrowings fell to $223.3m, but on the smaller EBITDA base net debt to EBITDA stepped up to 10.94x versus the 6.2x-6.8x range in the supplied historical baseline for stable operating periods. No dividend was declared for the period, and this section is confined to the cash and leverage facts rather than payout policy.

1. Continuing-operations NPAT of $5.6m is the cleaner read; PBT growth of 236.3% is also distorted by the negative prior base. The continuing EBITDA margin near 66% suggests the new infrastructure model can earn well, but on a far smaller revenue line than the historical refinery business.

2. Cash metrics are mixed, and the OCF/EBITDA ratio is denominator-distorted and suppressed in this period, so it should not be treated as a normal coverage or conversion signal. Pre-lease FCF at -$33.7m is $62.3m below the historical mean of +$28.6m. Capex consumed 63.2% of revenue, and inventory days at 31.6 sit well above the 13.4-15.7 day baseline. Cash fell from $34.5m to $8.0m; that decline is source-backed, but on the basis of a much smaller continuing-operations EBITDA denominator the ratio comparison above is not analytically comparable to prior periods.

3. Leverage stepped up despite lower nominal debt. Net debt of $215.3m against a much smaller annualised continuing EBITDA produces 10.94x leverage versus the 6.20x-6.80x stable-state range. Whether this is a transition reading depends on how quickly the new infrastructure model scales toward a steady-state EBITDA base; the same denominator discontinuity noted above for OCF/EBITDA applies to this leverage read as well.

Management commentary points to a "return to Dividends for FY22" but gives no payout shape, amount, or period basis (annual versus interim), so this reference should not be read as dividend guidance or as evidence of a resumed policy trend. The supplied second-half pattern shows HY21 was 57% of FY21 EBITDA, but the post-refinery business has no precedent for second-half weighting, so that template should not be applied mechanically.

Annualising current continuing EBITDA implies roughly $39m versus FY21 EBITDA of $72.8m, though the transition timing makes a clean annualisation unreliable. The release confirms a continuing-operations EBITDA margin of c.66%, which is a useful steady-state anchor but does not bound full-year volume or the residual conversion capex envelope.

Continuing-operations earnings appear genuine on margin but are early-cycle and partly aided by a $11.4m working-capital release. The supplied historical baseline classifies that release as below normal range (mean +$4.8m build), so reversibility should be assumed. Inventory days at 31.6 versus a 14.4-day mean point to a balance-sheet build, likely tied to transition stock dynamics rather than steady-state working-capital intensity.

The headline NPAT result is not durable in its current shape. It is supported by the after-tax discontinued-operation gain ($11.6m of the $17.2m total) and is contradicted by negative operating cash flow. The combination of -$33.7m pre-lease FCF, capex at 63.2% of revenue, and net debt to EBITDA at 10.94x means the reported earnings did not fund the period's cash needs; the balance sheet did, with cash drawn from $34.5m to $8.0m. As above, any coverage-style reading of operating cash flow against EBITDA in this period carries a denominator-distortion caveat and should not be treated as a normal-basis comparison.

This briefing cannot assess management's internal volume or margin trajectory for the converted import terminal beyond the disclosed c.66% continuing EBITDA margin reference, and it does not treat the current OCF/EBITDA ratio or the FY22 dividend reference as normal-basis, trend-comparable figures.